ES2120122T3 - Compuestos de vitamina d y metodo de preparar estos compuestos. - Google Patents

Compuestos de vitamina d y metodo de preparar estos compuestos.

Info

Publication number
ES2120122T3
ES2120122T3 ES95200063T ES95200063T ES2120122T3 ES 2120122 T3 ES2120122 T3 ES 2120122T3 ES 95200063 T ES95200063 T ES 95200063T ES 95200063 T ES95200063 T ES 95200063T ES 2120122 T3 ES2120122 T3 ES 2120122T3
Authority
ES
Spain
Prior art keywords
groups
compounds
individually
relates
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95200063T
Other languages
English (en)
Inventor
Mercedes Torneiro
Yagamare Fall
Antonio Mourino
Jan Zorgdrager
De Velde Jan-Paul Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2120122T3 publication Critical patent/ES2120122T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE VITAMINA D DE LA FORMULA GENERAL (I) EN LA QUE: R1 ES UN ATOMO DE HIDROGENO O UN GRUPO PROTECTOR HIDROXI; Z ES UN GRUPO DE FORMULA GENERAL (II) O (III) EN LA QUE R2 Y R3 SON CADA UNO, INDIVIDUALMENTE, GRUPOS ALQUILO (C1-C6), DE CADENA LINEAL O RAMIFICADA, SUSTITUIDOS O NO SUSTITUIDOS, GRUPOS ALQUENILO (C2-C6), GRUPOS CICLOALQUILO (C3-C6) O GRUPOS FENILO; O EN LA QUE R1 Y R3 JUNTO CON EL BIRRADICAL DE OXADIMETILENO DE INTERCONEXION FORMAN UN HEMIACETAL SUSTITUIDO POR ALQUILO (C1-C4) CERRADO CON UN ANILLO DE 5 A 7 MIEMBROS; CON LA CONDICION DE QUE R2 Y R3 NO SEAN LOS DOS O INDIVIDUALMENTE GRUPOS METILO; A Y B SON CADA UNO, INDIVIDUALMENTE, ATOMOS DE HIDROGENO O GRUPOS METILO O A Y B FORMAN JUNTOS UN GRUPO METILENO. LA INVENCION TAMBIEN SE REFIERE A UN METODO PARA LA PREPARACION DE ESTOS COMPUESTOS Y A SU USO EN FARMACOLOGIA. LA INVENCION TAMBIEN SE REFIERE A NUEVOS INTERMEDIOS UTILES.
ES95200063T 1994-01-20 1995-01-12 Compuestos de vitamina d y metodo de preparar estos compuestos. Expired - Lifetime ES2120122T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200131 1994-01-20

Publications (1)

Publication Number Publication Date
ES2120122T3 true ES2120122T3 (es) 1998-10-16

Family

ID=8216601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95200063T Expired - Lifetime ES2120122T3 (es) 1994-01-20 1995-01-12 Compuestos de vitamina d y metodo de preparar estos compuestos.

Country Status (9)

Country Link
EP (1) EP0664287B1 (es)
JP (1) JP3855280B2 (es)
AT (1) ATE168367T1 (es)
CA (1) CA2140382C (es)
DE (1) DE69503394T2 (es)
DK (1) DK0664287T3 (es)
ES (1) ES2120122T3 (es)
IL (1) IL112362A (es)
PL (1) PL179063B1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
CA2206876A1 (en) * 1994-11-21 1996-05-30 Wisconsin Alumni Research Foundation 18,19-dinor-vitamin d compounds
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
CN1254293A (zh) 1997-02-13 2000-05-24 骨疗国际公司 靶向治疗性给药维生素d化合物
BR0107479A (pt) * 2000-01-10 2002-09-03 Leo Pharma As Composto, composição farmacêutica, uso de um composto, e, método para o tratamento e/ou profilaxia de doenças

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DE69503394T2 (de) 1999-03-11
PL306849A1 (en) 1995-07-24
EP0664287A1 (en) 1995-07-26
DK0664287T3 (da) 1999-04-19
EP0664287B1 (en) 1998-07-15
CA2140382C (en) 2007-11-20
ATE168367T1 (de) 1998-08-15
PL179063B1 (pl) 2000-07-31
CA2140382A1 (en) 1995-07-21
JP3855280B2 (ja) 2006-12-06
DE69503394D1 (de) 1998-08-20
IL112362A0 (en) 1995-03-30
IL112362A (en) 2001-10-31
JPH07206813A (ja) 1995-08-08

Similar Documents

Publication Publication Date Title
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ES2139305T3 (es) Compuestos de vitamina d y metodo de preparar estos compuestos.
ES2120122T3 (es) Compuestos de vitamina d y metodo de preparar estos compuestos.
TW352383B (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
GR3005961T3 (es)
PT763024E (pt) Novos processos e intermediarios para a preparacao de derivados de piperazina
DE68911855D1 (de) 4-Substituierte-Anthracyclinone und Anthracyclin-Glycoside und Verfahren zu ihrer Herstellung.
ES2159659T3 (es) Procedimiento para la preparacion de derivados de sulfonilurea e intermedios para este procedimiento.
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
EP1112998A4 (en) AMINE DERIVATIVES
EP1072582A4 (en) INTERMEDIATES IN THE SYNTHESIS OF A RING UNIT OF THE VITAMIN DERIVATIVES SUBSTITUTED IN POSITION 2
HU9401003D0 (en) Process for producing new 4-androsteno[4,5-b]pyrrol derivatives
TW349935B (en) Oxime ether compounds, their intermediates and their use as pesticides
PT885232E (pt) Novos derivados do acido 1(2h)-quinolina-carboxilico processo para a sua preparacao e sua aplicacao para a sintese de produtos dotados de propriedadesantibioticas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 664287

Country of ref document: ES